Vis enkel innførsel

dc.contributor.authorOrmstad, Sari Susanna
dc.contributor.authorLund, Ulrikke Højslev
dc.contributor.authorChudasama, Kishan Kumar
dc.contributor.authorFrønsdal, Katrine Bjørnebek
dc.contributor.authorHov, Maren Ranhoff
dc.contributor.authorOrmberg, Ida
dc.contributor.authorHafstad, Elisabet Vivianne
dc.contributor.authorStoinska-Schneider, Anna
dc.contributor.authorRobberstad, Bjarne
dc.contributor.authorLauvrak, Vigdis
dc.contributor.authorJuvet, Lene Kristine
dc.date.accessioned2019-11-22T11:52:29Z
dc.date.available2019-11-22T11:52:29Z
dc.date.created2019-06-28T12:51:18Z
dc.date.issued2019
dc.identifier.isbn978-82-8406-005-7
dc.identifier.urihttp://hdl.handle.net/11250/2630060
dc.description.abstractKey message In Norway, approximately 12,000 persons experience acute stroke each year. Time is a crucial factor in the management of stroke, so rapid admission to a hospital for a computed tomography (CT) scan is recommended. A mobile stroke unit (MSU), an ambulance equipped with a CT scanner, helps bring the hospital to the patient. Research evidence indicates that, compared with conventional care of acute stroke, MSU care probably leads to: • reduced time from patient’s first contact with the emergency dispatch center to thrombolysis (treatment with a clot dissolving agent) • increased number of patients who receive thrombolysis MSU care may also lead to: • reduced time from patient’s first contact with the emergency dispatch center to CT imaging • better functionality at 3 months after stroke. Our cost- and threshold analysis found that: One MSU is estimated to cost approximately 6.4 million Norwegian kroner annually. The health gain measured in quality-adjusted life-years (QALYs) was 0.3 per patient receiving thrombolysis through MSU care compared with conventional care. We performed an analysis quantifying the severity criterion by calculating absolute shortfall for patients with acute ischemic stroke who receive conventional care. The results show an absolute shortfall of 5.5 QALYs. We found that the expected cost per QALY is approximately 385,000 Norwegian kroner or lower if one MSU successfully reaches at least 35-40% (145-171) of thrombolysis patients per year.
dc.language.isoeng
dc.publisherNorwegian Institute of Public Health, Division of Health Services
dc.relation.urihttps://www.fhi.no/publ/2019/prehospital-ct-for-tidlig-diagnostikk-og-behandling-ved-mistanke-om-hjernes/
dc.subject.meshStroke
dc.subject.meshCraniocerebral Trauma
dc.subject.meshTomography Scanners, X-Ray Computed
dc.subject.meshTomography, X-Ray Computed
dc.subject.meshAmbulances
dc.subject.meshMobile Health Units
dc.subject.meshTime-to-Treatment
dc.subject.meshTriage
dc.subject.meshTechnology Assessment, Biomedical
dc.subject.meshSystematic Review as Topic
dc.titlePrehospital CT for early diagnosis and treatment of suspected acute stroke or severe head injury. A health technology assessment
dc.title.alternativePrehospital CT for tidlig diagnostikk og behandling ved mistanke om hjerneslag eller alvorlige hodeskader. En metodevurdering
dc.typeResearch report
dc.description.versionpublishedVersion
dc.source.pagenumber142
dc.identifier.cristin1708615
cristin.unitcode7502,9,1,0
cristin.unitcode7502,5,1,0
cristin.unitcode7502,9,4,0
cristin.unitnameAvdeling for vurdering av tiltak
cristin.unitnameAvdeling for biobanker
cristin.unitnameAvdeling for global helse
cristin.ispublishedtrue
cristin.fulltextoriginal


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel